Immunochemical evidence that human apoB differs when expressed in rodent versus human cells

Journal of Lipid Research

Volumn 44, Issue 3, 2003, Pages 547-553

  Wang, Xingyu ^a,b   Chauhan, Vinita ^a   Nguyen, Anh T ^a   Schultz, Joshua ^a   Davignon, Jean ^c   Young, Stephen G ^d   Borén, Jan ^d,e   Innerarity, Thomas L ^d   Rutai, Hui ^b   Milne, Ross W ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b FUWAI HOSPITAL   (China)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d GLADSTONE INSTITUTES   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Apolipoprotein B; Hybridoma; Low density lipoproteins; Polymorphism

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; EPITOPE; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2E1; MONOCLONAL ANTIBODY 3D11; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNIZATION; IMMUNOCHEMISTRY; LIVER CELL; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TUMOR CELL LINE; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; RADIOIMMUNOASSAY; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOLIPOPROTEINS B; CELL LINE; EPITOPES; GENE EXPRESSION; HUMANS; HYBRIDOMAS; IMMUNOCHEMISTRY; LIPOPROTEINS, LDL; MICE; MICE, TRANSGENIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RADIOIMMUNOASSAY;

EID: 0037944245     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200413-JLR200     Document Type: Article

References (35)

1. Aviram, M., S. Lund-Katz, M. C. Phillips, and A. Chait. 1988. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprrotein B-100 with cells. J. Biol. Chem. 263: 16842-16848.
2. Galeano, N. F., R. Milne, Y. L. Marcel, M. T. Walsh, E. Levy, T. D. Nguyen, A. Gleeson, Y. Arad, L. Witte, M. Al-Haideri, S. C. Rumsey, and R. J. Deckelbaum. 1994. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J. Biol. Chem. 269: 511-519.
3. McNamara, J. R., D. M. Small, Z. L. Li, and E. J. Schaefer. 1996. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J. Lipid Res. 37: 1924-1935.
4. McKeone, B. J., J. R. Patsch, and H. J. Pownall. 1993. Plasma triglycerides determine low density lipoprotein composition, physical properities, and cell-specific binding in cultured cells. J. Clin. Invest. 91: 1926-1933.
5. Chen, G. C., W. Liu, P. Duchateau, J. Allaart, R. L. Hamilton, C. M. Mendel, K. Lau, D. A. Hardman, P. H. Frost, M. J. Malloy, and J. P. Kane. 1994. Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects. J. Biol. Chem. 269: 29121-29128.
6. Kleinman, Y., S. Eisenberg, Y. Oschry, D. Gavish, O. Stein, and Y. Stein. 1985. Defective metabolism of hypertriglyceridemic low density lipoproteins in cultured human skin fibroblasts. J. Clin. Invest. 75: 1796-1803.
7. Linton, M. F., R. V. Farese, G. Chiesa, D. S. Grass, P. Chin, R. E. Hammer, H. H. Hobbs, and S. G. Young. 1993. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 92: 3029-3037.
8. McCormick, S. P. A., J. K. Ng, M. Véniant, J. Borén, V. Pierotti, L. M. Flynn, D. S. Grass, A. Connolly, and S. G. Young. 1996. Transgenic mice that overexpress mouse apolipoprotein B - Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural gene. J. Biol. Chem. 271: 11963-11970.
9. Grass, D. S., U. Saini, R. H. Felkner, R. E. Wallace, W. J. P. Lago, S. G. Young, and M. E. Swanson. 1995. Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normal humans. J. Lipid Res. 36: 1082-1091.
10. Kim, E., and S. G. Young. 1998. Genetically modified mice for the study of apolipoprotein B. J. Lipid Res. 39: 703-723.
11. Kinoshita, M., E. S. Krul, and G. Schonfeld. 1990. Modification of core lipids of low density lipoproteins produces selective alterations in the expression of apoB-100 epitopes. J. Lipid Res. 31: 701-708.
12. Wang, X., R. Pease, J. Bertinato, and R. W. Milne. 2000. Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism. Arterioscler. Thromb. Vasc. Biol. 20: 1301-1308.
13. Butler, R. 1967. Polymorphisms of the human low-density lipoproteins. Vox Sang. 12: 2-17.
14. Rapacz, J., J. Hasler-Rapacz, K. M. Taylor, W. J. Checovich, and A. D. Attie. 1986. Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis. Science. 234: 1573-1577.
15. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
16. Borén, J., I. Lee, W. M. Zhu, K. Arnold, S. Taylor, and T. L. Innerarity. 1998. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J. Clin. Invest. 101: 1084-1093.
17. Braschi, S., N. Couture, A. Gambarotta, B. R. Gauthier, C. R. Coffill, D. L. Sparks, N. Maeda, and J. R. Schultz. 1998. Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse. Biochim. Biophys. Acta. 1392: 276-290.
18. Milne, R. W., P. K. Weech, and Y. L. Marcel. 1992. Immunological methods for studying and quantifying lipoproteins and apolipoproteins. In Lipoprotein Analysis: A Practical Approach. C. Converse and E. Skinner, editors. Oxford University Press, Oxford. 61-84.
19. Pease, R. J., R. W. Milne, W. K. Jessup, A. Law, P. Provost, J. C. Fruchart, R. T. Dean, Y. L. Marcel, and J. Scott. 1989. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. J. Biol. Chem. 265: 553-568.
20. Zlot, C. H., L. M. Flynn, M. M. Véniant, E. Kim, M. Raabe, S. P. McCormick, P. Ambroziak, L. M. McEvoy, and S. G. Young. 1999. Generation of monoclonal antibodies specific for mouse apolipoprotein B-100 in apolipoprotein B-48-only mice. J. Lipid Res. 40: 76-84.
21. Marcel, Y. L., M. Hogue, P. K. Weech, and R. W. Milne. 1984. Characterization of antigenic determinants on human solubilized apolipoprotein B: conformational requirements for lipids. J. Biol. Chem. 259: 6952-6957.
22. Ey, P. L., S. J. Prowse, and C. R. Jenkin. 1978. Isolation of pure IgG1, IgG2a, and lgG2b immunoglobulin from mouse serum using protein-A Sepharose. Immunochemisty. 15: 429-436.
23. Milne, R. W., R. Theolis, R. B. Verdery, and Y. L. Marcel. 1983. Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis. 3: 23-30.
24. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
25. Yao, Z., B. D. Blackhart, M. F. Linton, S. M. Taylor, S. G. Young, and B. J. McCarthy. 1991. Expression of carboxyl-terminally truncated forms of human apolipoprotein B in rat hepatoma cells. Evidence that the length of apolipoprotein B has a major effect on the buoyant density of the secreted lipoproteins. J. Biol. Chem. 266: 3300-3308.
26. 2 antagonists. J. Biol. Chem. 275: 25023-25030.
27. Markwell, M. A. K., S. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 265-275.
28. Bostrum, K., J. Borén, M. Wettesten, A. Sjoberg, G. Bondjers, O. Wiklund, P. Carlsson, and S. O. Olofsson. 1988. Studies on the assembly of apoB-100-containing lipoproteins in HepG2 cells. J. Biol. Chem. 263: 4434-4442.
29. Blackhart, B. D., Z. Yao, and B. J. McCarthy. 1990. An expression system for human apolipoprotein B100 in a rat hepatoma cell line. J. Biol. Chem. 265: 8358-8360.
30. Yang, C. Y., T. W. Kim, S. A. Weng, B. R. Lee, M. L. Yang, and A. M. Gotto, Jr. 1990. Isolation and characterization of sulfhydryl and disulfide peptides of human apolipoprotein B-100. Proc. Natl. Acad. Sci. USA. 87: 5523-5527.
31. Swaminathan, N., and F. Aladjem. 1976. The nonsaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins. Biochemistry. 15: 1516-1522.
32. Davis, R. A., G. M. Clinton, R. A. Borchardt, M. Malone-McNeal, T. Tan, and G. R. Lattier. 1984. Intrahepatic assembly of very low density lipoproteins. Phosphorylation of small molecular weight apolipoprotein B. J. Biol. Chem. 259: 3383-3386.
33. Lee, D. M. 1991. Implications of thiolester linked fatty acids in apolipoprotein B. Adv. Exp. Med. Biol. 285: 49-58.
34. Yang, C. Y., Z. Gu, S. Weng, T. W. Kim, S. H. Chen, H. J. Pownall, P. M. Sharp, S. W. Liu, W. H. Li, A. M. Gotto, and L. Chan. 1989. Structure of apoB-100 of human low density lipoproteins. Arteriosclerosis. 9: 96-108.
35. Zhao, Y., J. B. McCabe, J. Vance, and L. G. Berthiaume. 2000. Palmitoylation of apolipoprotein B is required for proper intracellular sorting and transport of cholesteroyl esters and triglycerides. Mol. Biol. Cell. 11: 721-734.